697 / 1542
30
Primary lung cancer
Clinical indications
Chang Lancet Oncol 2015
2 RCT (STARS & ROSEL) closed prematurely
because of poor accrual
pooled data of both trials
SABR surgery
N° pts
32
27
Fup (m)
40
35
Death
1
6
3y OS
95% 79%
3y RFS
86% 80%
Recurrences
Local
Regional node
Distant
1
4
1
0
1
2
Toxicity
Grade 3
Grade 4
Grade 5
3
0
0
10
1
1
54Gy/3fr
50Gy/5fr
60Gy/5fr
Lobectomy